Kenvue Stock Sinks Ahead of Trump Announcement Tying Autism to Tylenol Use During Pregnancy
1. Kenvue shares dropped 7% before Trump's autism report announcement. 2. Trump linked acetaminophen use in pregnancy to autism risk. 3. Kenvue stated no scientific link between acetaminophen and autism. 4. Stock recovered slightly in after-hours trading following the drop. 5. Kenvue expressed concern about public health implications from the announcement.